LU86163A1 - Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten - Google Patents

Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten Download PDF

Info

Publication number
LU86163A1
LU86163A1 LU86163A LU86163A LU86163A1 LU 86163 A1 LU86163 A1 LU 86163A1 LU 86163 A LU86163 A LU 86163A LU 86163 A LU86163 A LU 86163A LU 86163 A1 LU86163 A1 LU 86163A1
Authority
LU
Luxembourg
Prior art keywords
alk
ethyl acetate
independently represent
silibinin
animals
Prior art date
Application number
LU86163A
Other languages
German (de)
English (en)
Inventor
Reinhard Braatz
Klaus Goerler
Guenter Halbach
Hartwig Soicke
Karlheinz Schmidt
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of LU86163A1 publication Critical patent/LU86163A1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Silicon Compounds (AREA)
LU86163A 1984-11-22 1985-11-13 Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten LU86163A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843442639 DE3442639A1 (de) 1984-11-22 1984-11-22 Flavolignanderivate, verfahren zu deren herstellung und arzneimittel, die diese verbindungen enthalten
DE3442639 1984-11-22

Publications (1)

Publication Number Publication Date
LU86163A1 true LU86163A1 (de) 1986-03-24

Family

ID=6250903

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86163A LU86163A1 (de) 1984-11-22 1985-11-13 Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten

Country Status (29)

Country Link
JP (1) JPS61143377A (fr)
KR (1) KR870001020B1 (fr)
AR (1) AR240931A1 (fr)
AT (1) AT393268B (fr)
BE (1) BE903693A (fr)
CA (1) CA1337124C (fr)
CH (1) CH659473A5 (fr)
CS (1) CS273610B2 (fr)
DD (1) DD259191A1 (fr)
DE (1) DE3442639A1 (fr)
DK (1) DK164865C (fr)
EG (1) EG19424A (fr)
ES (1) ES8609311A1 (fr)
FI (1) FI84064C (fr)
FR (1) FR2573427B1 (fr)
GB (1) GB2167414B (fr)
HU (1) HU195503B (fr)
IE (1) IE58791B1 (fr)
IT (1) IT1190426B (fr)
LU (1) LU86163A1 (fr)
MX (1) MX168415B (fr)
NL (1) NL192387C (fr)
NO (1) NO160205C (fr)
PL (1) PL146890B1 (fr)
PT (1) PT81532B (fr)
SE (1) SE465676B (fr)
SU (1) SU1436875A3 (fr)
YU (1) YU43689B (fr)
ZA (1) ZA858951B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716918D0 (en) * 1987-07-17 1987-08-26 Inverni Della Beffa Spa Soluble derivatives of silybin
US5262439A (en) * 1992-04-30 1993-11-16 The Regents Of The University Of California Soluble analogs of probucol
ES2552108T3 (es) * 2005-03-11 2015-11-25 Howard Florey Institute Pty Ltd Compuestos flavonoides y usos de los mismos
JP5349486B2 (ja) 2007-11-15 2013-11-20 マダウス ゲーエムベーハー 肝炎の治療のためのシリビニン成分
RU2482844C2 (ru) * 2007-11-15 2013-05-27 Мадаус Гмбх Силибининовый компонент для лечения гепатита
AU2010247716B2 (en) * 2009-05-14 2015-11-05 Madaus Gmbh Amorphous silibinin for the treatment of viral hepatitis
WO2014008353A2 (fr) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprenant du sulforaphane ou un précurseur de sulforaphane et un extrait ou une poudre de champignon
CN103172622B (zh) * 2013-02-22 2015-11-04 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯的活性异构体
CN103193768B (zh) * 2013-02-22 2016-03-30 西安安健药业有限公司 治疗肝病的水飞蓟宾二偏琥珀酸酯异构体
CN103113359B (zh) * 2013-02-22 2016-01-06 西安安健药业有限公司 水飞蓟宾二偏琥珀酸酯及其药用盐

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963318A1 (de) * 1969-12-17 1971-06-24 Schwabe Willmar Gmbh & Co Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten

Also Published As

Publication number Publication date
CS837885A2 (en) 1990-08-14
JPH0432073B2 (fr) 1992-05-28
GB8528226D0 (en) 1985-12-18
DK537785D0 (da) 1985-11-21
NL192387C (nl) 1997-07-04
DE3442639A1 (de) 1986-05-22
AT393268B (de) 1991-09-25
PT81532A (de) 1985-12-01
FI854535A (fi) 1986-05-23
NO854655L (no) 1986-05-23
SE8505487D0 (sv) 1985-11-20
ES549116A0 (es) 1986-09-01
IE58791B1 (en) 1993-11-17
ZA858951B (en) 1986-08-27
FI84064C (fi) 1991-10-10
MX168415B (es) 1993-05-24
PL146890B1 (en) 1989-03-31
SE465676B (sv) 1991-10-14
KR860004056A (ko) 1986-06-16
CH659473A5 (de) 1987-01-30
YU43689B (en) 1989-10-31
JPS61143377A (ja) 1986-07-01
IE852808L (en) 1986-05-22
DK164865C (da) 1993-01-18
FI84064B (fi) 1991-06-28
DK164865B (da) 1992-08-31
GB2167414B (en) 1989-01-11
NO160205C (no) 1989-03-22
PL256374A1 (en) 1986-12-02
HU195503B (en) 1988-05-30
FR2573427B1 (fr) 1989-03-10
HUT40114A (en) 1986-11-28
FR2573427A1 (fr) 1986-05-23
DE3442639C2 (fr) 1989-08-10
PT81532B (pt) 1987-11-11
CA1337124C (fr) 1995-09-26
ES8609311A1 (es) 1986-09-01
BE903693A (fr) 1986-05-22
KR870001020B1 (ko) 1987-05-23
DK537785A (da) 1986-05-23
IT8522932A0 (it) 1985-11-21
SU1436875A3 (ru) 1988-11-07
AR240931A2 (es) 1991-03-27
EG19424A (en) 1995-02-28
ATA337185A (de) 1991-02-15
NL8503171A (nl) 1986-06-16
IT1190426B (it) 1988-02-16
FI854535A0 (fi) 1985-11-18
NL192387B (nl) 1997-03-03
DD259191A1 (de) 1988-08-17
GB2167414A (en) 1986-05-29
AR240931A1 (es) 1991-03-27
NO160205B (no) 1988-12-12
SE8505487L (sv) 1986-05-23
CS273610B2 (en) 1991-03-12
YU178685A (en) 1988-02-29

Similar Documents

Publication Publication Date Title
DE2549783C3 (de) Triglyceride mit entzündungshemmender Wirkung
DE2711927A1 (de) Pharmazeutisch wirksame polyphenole und verfahren zu ihrer herstellung
EP0149242A2 (fr) 1-(2-Hydroxyaryl)-alcan-1-one oxime, préparation et utilisation en pharmacie
AT391315B (de) Verfahren zur herstellung von isosilybinfreiem silibinin
LU86163A1 (de) Flavolignanderivate,verfahren zu deren herstellung und arzneimittel,die diese verbindungen enthalten
EP0472501A2 (fr) Sel de codéine et d'un acide carbonique substitué, procédé pour sa préparation, son utilisation et préparations pharmaceutiques
DE69105767T2 (de) Bilobalid-Phospholipid-Komplexe, ihre Anwendung und Zusammensetzungen enthaltend diese.
EP0520414B1 (fr) Procédé d'obtention de diacétylrhéine
DE69019517T2 (de) Neolignanderivatkomplexen mit Phospolipiden, deren Verwendung und sie enthaltende pharmazeutische und kosmetische Zusammensetzungen.
EP0127726A1 (fr) Acides hydroxamiques, procédé pour leur préparation et leur utilisation dans des compositions pharmaceutiques
DE102004032440A1 (de) Verwendung von trisubstituierten Benzopyranonen
DE69927813T2 (de) Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen
DE2434929C2 (de) p-Acetylaminophenolester von Phenylsalicylsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0501206B1 (fr) Dérivés de phénones, procédé pour leur préparation et leurs compositions pharmaceutiques
CH633715A5 (de) Verfahren zur erzeugung einer antilithiatisch wirkenden substanz und ein antilithiaticum.
EP0664131A1 (fr) Extraits de kava à libération optimale
DE2847836C3 (de) Verfahren zur Gewinnung eines Terpengemisches mit antipsoriatischer Wirksamkeit
EP0544880B1 (fr) Procede de preparation de diacetylrheine
DE2243777A1 (de) Dihydrochinolinderivate, ihre verwendung und verfahren zur herstellung derselben
DE2503135C3 (de) Terpenverbindungen, Verfahren zu ihrer Herstellung und diese Produkte enthaltende Arzneimittel
EP0310757A1 (fr) Procédé d'obtention d'un extrait à l'éthanol de propolis
DE2415982A1 (de) Ester von 2- eckige klammer auf (chinolyl-4')-amino eckige klammer zu -benzoesaeuren
DE2609533A1 (de) Verfahren zur extraktion von wirkstoffen, insbesondere von heterosidestern, der kaffeesaeure, sowie diese verbindungen enthaltende arzneimittel
DE60124315T2 (de) Eine aus der pflanze humboldtia decurrens gewonnene antidiabetische verbindung und ein verfahren zu ihrer herstellung
DE2707675A1 (de) Arzneimittel zur aufloesung bzw. teilweisen aufloesung von gallensteinen